2013
DOI: 10.1177/0300060513477291
|View full text |Cite
|
Sign up to set email alerts
|

CYP19A1 gene polymorphisms and risk of lung cancer

Abstract: Polymorphisms of CYP19A1 may be related to the increased risk of lung cancer; in particular, haplotype ACA may contribute to lung-cancer progression in nonsmokers. Further validation with larger populations is required.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
13
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 17 publications
(16 reference statements)
0
13
0
Order By: Relevance
“…Zhang et al have shown that CYP19A1-rs727479 was signi cantly associated with the incidence of lung cancer. In particular, haplotype rs727479|rs730154|rs10046-ACA was only signi cantly associated with nonsmokers and female nonsmokers 17 .…”
Section: Discussionmentioning
confidence: 90%
See 2 more Smart Citations
“…Zhang et al have shown that CYP19A1-rs727479 was signi cantly associated with the incidence of lung cancer. In particular, haplotype rs727479|rs730154|rs10046-ACA was only signi cantly associated with nonsmokers and female nonsmokers 17 .…”
Section: Discussionmentioning
confidence: 90%
“…SNPs in CYP19A1 were found to be associated with cancer risk in European Americans, North Indians, and Chinese 24,25 . In particular, CYP19A1 SNPs have been shown to be signi cantly associated with lung-related diseases 16,17 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This suggests that CYP19A1 genetic variation may indirectly affect the progression of lung cancer, but the exact mechanism is unclear. At the same time, many literatures have reported the inseparable relationship between CYP19A1 gene and lung-related diseases, including lung cancer (15)(16)(17).…”
Section: Introductionmentioning
confidence: 99%
“…Current data show that all cancer types are in some way related with the level of estrogen, estrogen receptors and aromatase or their polymorphisms [11][12][13][14]. Generally estrogen receptor (ER) alpha promotes proliferation, while ER beta supresses it but this is not the rule for all tissues; moreover, the ER status varies between neoplastic tissues.…”
Section: Introductionmentioning
confidence: 99%